Cargando…

MiR-153-5p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Paclitaxel by Inducing G2M Phase Arrest

BACKGROUND: Paclitaxel (PTX) resistance is a main obstacle for the treatment of triple-negative breast cancers (TNBC). Evidences have shown that miR-153-5p could induce the apoptosis of breast cancer cells. Thus, this study aimed to investigate the effect of miR-153-5p on PTX-resistance TNBC cells....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yang, Wu, Nan, Zhang, Jun, Wang, Huidong, Men, Xiaojuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231778/ https://www.ncbi.nlm.nih.gov/pubmed/32494162 http://dx.doi.org/10.2147/OTT.S241640

Ejemplares similares

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
por: Fkih M’hamed, Insaf, et al.
Publicado: (2015)

A comprehensive review on miR-153: Mechanistic and controversial roles of miR-153 in tumorigenicity of cancer cells
por: Yousefnia, Saghar
Publicado: (2022)

Upregulation Of miR-153 Inhibits Triple-Negative Breast Cancer Progression By Targeting ZEB2-Mediated EMT And Contributes To Better Prognosis
por: Shi, Dongliang, et al.
Publicado: (2019)

SNHG15 affects the growth of glioma microvascular endothelial cells by negatively regulating miR-153
por: Ma, Yawen, et al.
Publicado: (2022)

Expression of miR-210, miR-137, and miR-153 in Patients with Acute Cerebral Infarction
por: Tian, Hongtao, et al.
Publicado: (2021)

Mifepristone Derivative FZU-00,003 Suppresses Triple-negative Breast Cancer Cell Growth partially via miR-153-KLF5 axis
por: Liu, Rong, et al.
Publicado: (2020)

The potential of miR-153 as aggressive prostate cancer biomarker
por: Gilyazova, Irina, et al.
Publicado: (2022)

miR-107 Enhances the Sensitivity of Breast Cancer Cells to Paclitaxel
por: Ma, Changpo, et al.
Publicado: (2019)

Plasma miR-153 and miR-223 Levels as Potential Biomarkers in Parkinson’s Disease
por: Wu, Li, et al.
Publicado: (2022)

miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
por: Huang, Qian, et al.
Publicado: (2018)

Downregulation of miR-7 and miR-153 is involved in Helicobacter pylori CagA induced gastric carcinogenesis and progression
por: Song, Yu, et al.
Publicado: (2023)

miR-153 Regulates SNAP-25, Synaptic Transmission, and Neuronal Development
por: Wei, Chunyao, et al.
Publicado: (2013)

Aberrant expression of miR-153 is associated with the poor prognosis of cervical cancer
por: Liu, Li, et al.
Publicado: (2018)

Cucurbitacin E Induces Cell Cycle G2/M Phase Arrest and Apoptosis in Triple Negative Breast Cancer
por: Kong, Yanjie, et al.
Publicado: (2014)

MiR-153 regulates expression of hypoxia-inducible factor-1α in refractory epilepsy
por: Gong, Guo-Hua, et al.
Publicado: (2018)

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
por: Wang, Meng, et al.
Publicado: (2021)

Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
por: Huang, Qian, et al.
Publicado: (2018)

Gambogic acid increases the sensitivity to paclitaxel in drug-resistant triple-negative breast cancer via the SHH signaling pathway
por: Wang, Yonghui, et al.
Publicado: (2019)

Increased expression of miR-153 predicts poor prognosis for patients with prostate cancer
por: Bi, Cheng-wei, et al.
Publicado: (2019)

Integrated network analysis identifies hsa-miR-4756-3p as a regulator of FOXM1 in Triple Negative Breast Cancer
por: Gu, Yuanliang, et al.
Publicado: (2019)

miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity
por: O'Brien, Keith, et al.
Publicado: (2015)

Co-regulation of intragenic microRNA miR-153 and its host gene Ia-2β: identification of miR-153 target genes with functions related to IA-2β in pancreas and brain
por: Mandemakers, W., et al.
Publicado: (2013)

A Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma Cells
por: Patil, Ketan S., et al.
Publicado: (2015)

Role of miR153 and miR455-5p Expression in Oral Squamous Cell Carcinoma Isolated from Plasma
por: Baber, Sajjad, et al.
Publicado: (2021)

Involvement of miR-15a in G0/G1 Phase Cell Cycle Arrest Induced by Porcine Circovirus Type 2 Replication
por: Quan, Rong, et al.
Publicado: (2016)

Secreted miR-153 Controls Proliferation and Invasion of Higher Gleason Score Prostate Cancer
por: Bertoli, Gloria, et al.
Publicado: (2022)

Transcytosable Peptide-Paclitaxel Prodrug Nanoparticle for Targeted Treatment of Triple-Negative Breast Cancer
por: Wang, Longkun, et al.
Publicado: (2023)

Morphine counteracts the effects of paclitaxel in triple-negative breast cancer cells
por: Sezer, Gülay, et al.
Publicado: (2022)

A Novel Paclitaxel Derivative for Triple-Negative Breast Cancer Chemotherapy
por: Liu, Yuetong, et al.
Publicado: (2023)

miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines
por: Ninio-Many, Lihi, et al.
Publicado: (2020)

The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosis
por: Feng, Zhanzhan, et al.
Publicado: (2018)

Author Correction: Integrated network analysis identifies hsa-miR-4756-3p as a regulator of FOXM1 in Triple Negative Breast Cancer
por: Gu, Yuanliang, et al.
Publicado: (2021)

Aberrant expression of miR-153 is associated with overexpression of hypoxia-inducible factor-1α in refractory epilepsy
por: Li, Yaohua, et al.
Publicado: (2016)

MiR-9, miR-153 and miR-124 are down-regulated by acute exposure to cocaine in a dopaminergic cell model and may contribute to cocaine dependence
por: Cabana-Domínguez, Judit, et al.
Publicado: (2018)

Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial
por: Yu, Ke-Da, et al.
Publicado: (2020)

CCT020312 Inhibits Triple-Negative Breast Cancer Through PERK Pathway-Mediated G1 Phase Cell Cycle Arrest and Apoptosis
por: Li, Xiaoli, et al.
Publicado: (2020)

Anticancer Effects and Molecular Action of 7-α-Hydroxyfrullanolide in G2/M-Phase Arrest and Apoptosis in Triple Negative Breast Cancer Cells
por: Chimplee, Siriphorn, et al.
Publicado: (2022)

miR-7 and miR-153 protect neurons against MPP(+)-induced cell death via upregulation of mTOR pathway
por: Fragkouli, Apostolia, et al.
Publicado: (2014)

Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates
por: Bertoli, Gloria, et al.
Publicado: (2021)

RAD6 inhibition enhances paclitaxel sensitivity of triple negative breast cancer cells by aggravating mitotic spindle damage
por: Haynes, Brittany M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_55nf368snlhonf4ac6qishsjoi